Samara Capital Partners has acquired the Indian rights to a portfolio of drug brands from Swiss pharmaceutical company Novartis.
Financial details of the transaction were not disclosed. The portfolio mainly comprises anti-infective drugs aimed at women, and includes exclusive rights to Cofvector, Monkezin and Glyred and a license...
Team turnover remains a key concern for LPs making commitments to Chinese private equity firms, but even the most stable of GPs must demonstrate an ability to evolve in response to a fast-changing environment, investors caution.
Redpoint China Ventures has closed its debut renminbi-denominated VC fund at RMB700 million ($110 million).
India’s National Investment & Infrastructure Fund has acquired a controlling stake in PE-backed logistics player Continental Warehousing Corporation (CWCNSL) in a joint deal with Dubai-based port operator DP World.
HarbourVest Partners has closed its latest fund-of-funds targeting European and Asian markets with $1.7 billion in commitments.